Non-Vanderbilt fans may be surprised at which league player could lead the voting at next week's Southeastern Conference media days in Atlanta.

AbbVie and Anima Biotech have announced that they are collaborating in a deal worth up to over $580 million to discover and develop drugs that modulate mRNA biology for three targets in cancer and ...